We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Consort Medical Plc | LSE:CSRT | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,010.00 | 1,005.00 | 1,010.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCSRT
RNS Number : 7381J
Consort Medical PLC
06 December 2018
Consort Medical plc
Director Shareholding
6 December 2018
Consort Medical plc (the 'Company') announces that Paul Hayes, Chief Financial Officer purchased 4,000 ordinary 10p shares at an aggregated price of GBP7.624 per share on 5 December 2018. Following this transaction Mr Hayes holds 12,212 ordinary shares in the Company.
The Notification of Dealing Form set out below is provided in accordance with the requirements of the Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Paul Hayes --------------------------------------- ---------------------------------- 2 Reason for the notification --------------------------------------------------------------------------- a) Position/status Chief Financial Officer --------------------------------------- ---------------------------------- b) Initial notification Initial Notification /Amendment --------------------------------------- ---------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --------------------------------------------------------------------------- a) Name Consort Medical plc --------------------------------------- ---------------------------------- b) LEI 2138001TBP74FD66QT38 --------------------------------------- ---------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --------------------------------------------------------------------------- a) Description of the Ordinary Shares of 10p each financial instrument, type of instrument Identification code ISIN: GB0000946276 b) Nature of the transaction Acquisition --------------------------------------- ---------------------------------- c) Price(s) and volume(s) --------------- -------------- Price(s) Volume(s) --------------- -------------- GBP7.656 1,000 ------------------------------------------------------------ -------------- GBP7.613 2,000 ------------------------------------------------------------ -------------- GBP7.613 1,000 ------------------------------------------------------------ -------------- d) Aggregated information - Aggregated volume 4,000 - Price GBP7.624 e) Date of the transaction 2018-12-05 --------------------------------------- ---------------------------------- f) Place of the transaction London Stock Exchange XLON --------------------------------------- ----------------------------------
Enquiries: Michelle Palmer, Assistant Company Secretary 01442 8867920
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHDQLFBVLFFFBE
(END) Dow Jones Newswires
December 06, 2018 12:18 ET (17:18 GMT)
1 Year Consort Medical Chart |
1 Month Consort Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions